Abstract:Background. Because of the importance of vitamin D (VitD) in calcium balance and bone health, the body has evolved effective homeostatic mechanisms to maintain 1,25-dihydroxyvitamin D [1,25(OH) 2 D] — the biologically active form — in a narrow physiological range. Objective and hypothesis. We developed a mathematical model to investigate homeostatic mechanisms regulating VitD metabolism with the objective of elucidating regulatory mechanisms maintaining levels of 1,25(OH) 2 D within a narrow physiological range despite wide variation in availability of VitD. Methods. We studied 11 otherwise healthy VitD deficient [25(OH)D<20 ng/mL] participants before and after VitD3 supplementation (50,000 IU once or twice a week depending on BMI for 4-6 weeks). We measured 25(OH)D, 1,25(OH) 2 D, 24,25(OH) 2 D, PTH, and FGF23. We used a 2-tailed paired Student’s t-test to analyze our data; p=0.05 was selected as the criterion for statistical significance. This represents a secondary analysis of a previously published clinical trial [Shahidzadeh Yazdi et al. (2023) J Clin Endocrinol Metab, doi: 10.1210/clinem/dgad554]. Results. VitD3 supplements induced a significant 2.7-fold increase (p=0.0006) in mean 25(OH)D and a 4.3-fold increase (p=0.0002) in 24,25(OH) 2 D, but did not change 1,25(OH) 2 D, PTH, or FGF23. Our model showed that 24-hydroxylase activity was regulated over a 10-fold range — with maximal induction for 25(OH)D>50 ng/mL and maximal suppression for 25(OH)D<10-20 ng/mL). Because 24-hydroxylase catalyzes metabolic clearance of 1,25(OH) 2 D, high levels protect against VitD toxicity and low levels preserve 1,25(OH) 2 D when VitD is scarce. Thus, suppression of 24-hydroxylase activity is a homeostatic mechanism reflecting the body’s perception of VitD deficiency. Accordingly, measurements of 24,25(OH) 2 D levels can contribute to assessment of VitD status. However, measurements of total levels of all VitD metabolites [including 24,25(OH) 2 D] are confounded by the ~3-fold inter-individual variation in VitD binding protein (VDBP) levels. Fortunately, the ratio of 1,25(OH) 2 D /24,25(OH) 2 D is independent of VDBP levels. Our analysis suggests that this ratio provides a superior assessment of VitD status compared to the current recommendation to measure total 25(OH)D. For example, 24-hydroxylase activity is highly correlated with 1,25(OH) 2 D /24,25(OH) 2 D (ρ 2 =0.91) but less well correlated with 25(OH)D (ρ 2 =0.91). Conclusions. The body has two defense mechanisms to protect against VitD deficiency. The first line of defense is suppression of 24-hydroxylase, which is triggered by mild-moderate VitD deficiency and preserves VitD from degradation. However, at times of severe VitD deficiency, the first line of defense may be insuffcient to maintain 1,25(OH) 2 D in a physiological range. Therefore, the body triggers a second line of defense — secondary hyperparathyroidism, which in turn upregulates 1-hydroxylation and increases production of 1,25(OH) 2 D. By better understanding the physiology of homeostatic regulation of VitD metabolism, physicians can advance the state-of-the-art in diagnosing and treating VitD deficiency. Funding: R01DK118942; T32DK098107. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

In vivo contribution of promoter vitamin D response elements

In vivo contribution of Cyp24a1 promoter vitamin D response elements

Mechanistic homeostasis of vitamin D metabolism in the kidney through reciprocal modulation of Cyp27b1 and Cyp24a1 expression

A kidney-specific genetic control module in mice governs endocrine regulation of the cytochrome P450 gene Cyp27b1 essential for vitamin D3 activation

Spatial detection and consequences of nonrenal calcitriol production as assessed by targeted mass spectrometry imaging

Regulation of 1 and 24 hydroxylation of vitamin D metabolites in the proximal tubule

Extrarenal expression of the 25-hydroxyvitamin D-1-hydroxylase

Regulation of vitamin D metabolizing enzymes in murine renal and extrarenal tissues by dietary phosphate, FGF23, and 1,25(OH)2D3

[Influence of Vitamin D Receptor FokI Polymorphism on Expression of CYP24A1 in Periodontal Cells].

VDR promotes testosterone synthesis in mouse Leydig cells via regulation of cholesterol side chain cleavage cytochrome P450 (Cyp11a1) expression

Pancreatic metastasis of a pleuropulmonary blastoma in an adult.

The Role of Intestinal Cytochrome P450s in Vitamin D Metabolism

Gene Expression Profiling of 1α,25(OH)2 D3 Treatment in 2D/3D Human Hepatocyte Models Reveals CYP3A4 Induction but Minor Changes in Other Xenobiotic-Metabolizing Genes

Expression and Activity of Vitamin D-Metabolizing Cytochrome P450s (cyp1α and CYP24) in Human Nonsmall Cell Lung Carcinomas*

Genomically anchored vitamin D receptor mediates an abundance of bioprotective actions elicited by its 1,25-dihydroxyvitamin D hormonal ligand

Critical Role for 24-Hydroxylation in Homeostatic Regulation of Vitamin D Metabolism

Anatomical Location of Pathology Is Predictive of Prolonged Fluoroscopy Time During ERCP: A Multicenter American Study

Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption

Modulation of vitamin D signaling by the pioneer factor CEBPA

The Role of 24-hydroxylase in Homeostatic Regulation of 1,25-dihydroxyvitamin D

The Vitamin D Metabolite Diagnostic Ratio Associates With Phenotypic Traits of Idiopathic Hypercalciuria